Post on 01-Apr-2015
AU ROADMAP ON SHARED RESPONSIBILITY AND GLOBAL SOLIDARITY FOR AIDS, TB AND MALARIA
ADDIS ABABA, ETHIOPIA
Parliamentary Roundtable25-26 March 2014
Heads of State and Government (Africa-
wide)
AWA Champions
AWA Consultative Experts Committee
(MS)
AWA Secretariat
AWA Chairperson -MauritaniaAWA Vice Chairperson - Mozambique
East AfricaTanzania
North AfricaTunisia Southern Africa
Malawi West Africa Cote d’lvoire
Central Africa Gabon
Brief Background: AU Roadmap on Shared
Responsibility and Global Solidarity 2012 -2015
The Roadmap presents a set of practical African-sourced solutions for enhancing Shared Responsibility and Global Solidarity for AIDS, TB, and Malaria responses in Africa.
The overarching goal of the AU Roadmap is to support African countries to exercise leadership to meet AIDS, TB, malaria targets by 2015 and source African solutions to ensure universal access to health-related services for all those in need on a sustainable basis. The AU Roadmap builds on a number of AU initiatives (e.g. Abuja Declaration)
This practical guide has been developed with indicators to assist the, the African Member States, RECs and other relevant stakeholders to implement the AU Roadmap.
The AU Roadmap suggested solutions are organised around three strategic pillars:
AU Roadmap Three Pillars
1More diversified,
balanced and sustainable financing
models
2Access to medicines
– local production and regulatory harmonisation
3 Leadership, governance
and oversight for sustainability
The Roadmap: three action pillars
1 More diversified,
balanced and sustainable financing
models
Develop financial sustainability plans with clear targets
Ensure development partners meet commitments and align with Africa’s priorities
Maximise opportunities to diversify funding sources and increase domestic resource allocation
Invest in leading medicines manufacturers – focusing on AIDS, TB and malaria
Lay foundations for a single African regulatory agency
Acquire essential skills through technology transfers and south-south cooperation
Incorporate TRIPS flexibilities and avoid "TRIPS-plus" measures in trade agreements
Use strategic investment approaches for scale-up of basic programmes
Support communities to claim their rights and participate in governance of the responses
Ensure investments contribute to health system strengthening
Mobilise leadership at all levels to implement the Roadmap
3 Leadership,
governance and oversight for sustainability
2 Access to medicines – local production and
regulatory harmonisation
Priority actions
5
AU Roadmap Practical guide: Pillar No. 1
Level Action
National • Analyzing the costs of the three diseases• Building a picture of ‘returns on investment’• Identify innovative sources of domestic funding Building a picture of
‘returns on investment’• Identify innovative sources of domestic funding (see examples in
Guide)• Work with development partners to ensure they meet their funding
commitments
Regional Facilitate sharing of ideas and lessons learned on diversifying and innovating funding
Continental Monitor and report on progress of member states on biennial basis
AU Roadmap Practical guide: Pillar No. 2
Level Action
National • Promote and facilitate investing in leading medicines (e.g ARVs, ACTs, TB.) and health commodities (e.g. ITNs, insecticides) manufacturers in country.
• Create an enabling regulatory environment within country in order to reduce import tariffs and harmonize regulatory requirements with other countries in the region
• Create a legislative environment that incorporates the full use of TRIPS flexibilities
Regional • Undertake functions as defined in African Medicines Regulatory Harmonisation (AMRH) initiative and Pharmaceutical Manufacturing Plan for Africa (PMPA) business plan in the region
• Work to identify leading companies that can be supported to build their capacity so become quality assured pharmaceutical and commodities (e.g. ITNs) manufacturers in the region for core drugs for the three diseases.
Continental • Lead on attracting external investors into the continent• Advocate at high levels in all member states for sustained attention
and investment in pharmacy and commodity manufacturing and regulatory harmony, including through continued support for PMPA and AMRH
• Establish a Pharma Market Data Initiative• Lay the foundations for a single African regulatory authority• advocate at a global level for continuation of TRIPS flexibilitiies
AU Roadmap Practical guide: Pillar No. 3
Level Action
National • Understand the scale of the three diseases• Use existing reviews of disease programme governance and
management arrangements to determine where capacity exists to drive forward achieving AU Roadmap objectives
• Develop strategy for engaging people living with HIV, civil society, key populations, national human rights entities and parliamentarians as partners in implementation and oversight of the Roadmap
• Determine responsibility and accountability for oversight and reporting on Roadmap progress
Regional • Facilitate regional multi-stakeholder (including civil society) peer review of Roadmap implementation, including review of national strategies, investment cases, governance arrangements, adherence to human rights agreements and drug regulatory policies and frameworks
• Organise annual regional forums to share experiences and best practices on achieving Roadmap targets
Continental • Put in place biennial reporting on AU Roadmap Implementation progress against indicators, starting with reporting at the AU Summit in 2014.
• Monitor the degree to which both AU member state governments and development partners are meeting their funding commitments
• Agree with African Peer Review Mechanism the inclusion of indicators on leadership, governance and oversight for the AU Roadmap within the self-assessment form and peer review process.
• Set up an AU award to go those countries with highest achievement as far as progress towards reaching AU Roadmap targets.
AU Roadmap on Shared Responsibility and Global Solidarity for HIV/AIDS, TB and Malaria (2012-2015)
Period Milestones
July 2012 AU Roadmap, adopted by AU Assembly
July 2012 AU Roadmap Practical Guide was developed with Indicators
July 2012 High-Level Ministerial Dialogue on Value for Money, Sustainability and Accountability in the Health sector calls for reducing aid dependence
July 2012 African Leaders Malaria Alliance (ALMA) Summit on malaria calls for increased domestic financing and innovative financing
Sept 2012 United Nations General Assembly African Union High-Level Side Event on Shared Responsibility and Global Solidarity for AIDS
March 2013 Pan-African Parliament commits to monitoring the implementation of the AU
May 2013 First Year - AU Roadmap was produced
July 2013
AU Roadmap on Shared Responsibility and Global Solidarity for HIV/AIDS, TB and Malaria (2012-2015) cont…
Period Milestones
Nov 2013 First Year - AU Roadmap was produced
July 2012 Abuja Special Summit called for acceleration of the implementation of the AU Roadmap on Shared Responsibility and Global Solidarity for HIV/AIDS, TB and Malaria Response in Africa and strengthen the accountability platform;
July 2012 Ministerial Meeting on Domestic Health Financing
AWA Champions - strategic platform to implement AU Roadmap
The AWA meeting in May 2013, appointed Mozambique President Armando Guebuza as the Vice-Chairperson of AWA. The AWA “champions” are as follows:
President Alassane Ouattara of Côte d’Ivoire - West Africa; President Ali Bongo Ondimba of Gabon - Central Africa; President Jakaya Kikwete of the United Republic of Tanzania - East Africa; President Joyce Banda of Malawi - Southern Africa; President Moncef Marzouki, of the Democratic Republic of Tunisia - North
Africa.
Example: Leadership of AWA Champion in Implementation of AU Roadmap The President of Malawi, SADC Chairperson and SADC AWA
Champion Special Breakfast Summit of SADC Heads of States and
Government, margins of 33rd SADC Summit Aim to discuss progress and challenges that the region is facing in
the areas of HIV and AIDS, TB and Malaria SADC AWA Summit directed SADC Ministers of Health and
Ministers responsible for HIV and AIDS to deliberate on the above issues and present their recommendations at the next Summit in 2014.